An interventional study of Enamel Etching time for 5 seconds and Ambar Universal Plus; FGM in Non-Carious Cervical Lesions (NCCLs), sponsored by Universidad de los Andes, Chile. Completed at 1 site in Chile. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Universidad de los Andes, Chile · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The aim of this study will be to evaluate the effect of reduced enamel etching time on the 6, 12, 18 and 24-months clinical performance of two universal adhesive systems used as etch-and-rinse application mode in non-carious cervical lesions (NCCLs).
Materials \& Methods: 140 restorations will be randomly placed in 35 subjects according to the following groups: AUP5 (Ambar Universal APS Plus adhesive on enamel etched for 5 seconds); AUP15 (Ambar Universal APS Plus adhesive on enamel etched for 15 seconds); SUB5 (Solare Universal Bond adhesive on enamel etched for 5 seconds); SUB15 (Solare Universal Bond adhesive on enamel etched for 15 seconds). All groups will be light-cured for 10s/1,000 mW/cm2. A resin composite will be placed by applying three increments and each one will be light cured for 20s/1,000 mW/cm2. The restorations will be finished immediately with fine diamond burs and polishers. The restorations will be evaluated at baseline and after 6, 12, 18 and 24-months by using the FDI criteria. The following outcomes will be evaluated: retention, marginal staining, marginal adaptation, post-operative sensitivity and recurrence of caries. The differences among the groups will be calculated using Friedman repeated measures analysis of variance rank (α = 0.05).
This is a four-arm, double-blind, randomized controlled clinical trial. Experimental group 1: 35 non-carious cervical lesions (NCCL) will receive composite resin restorations using an universal adhesive (Ambar Universal APS Plus; FGM) on enamel etched for 5 seconds in the selective enamel etching application strategy. Experimental group 2: 35 non-carious cervical lesions (NCCL) will receive composite resin restorations using an universal adhesive (Solare Bond Universal; GC) on enamel etched for 5 seconds in the selective enamel etching application strategy. Control group 1: 35 non-carious cervical lesions (NCCL) will receive composite resin restorations using an universal adhesive (Ambar Universal APS Plus; FGM) on enamel etched for 15 seconds in the selective enamel etching application strategy.
Control group 2: 35 non-carious cervical lesions (NCCL) will receive composite resin restorations using an universal adhesive (Solare Bond Universal; GC) on enamel etched for 15 seconds in the etch-and-rinse application strategy.
LCNCs will be randomized to universal adhesive usage and enamel etching time. All groups will be light-cured with a lightcuring device (SmartLite Focus, Dentsply) with a light intensity of 900 mW/cm² for 10 seconds. Operators will restore the cervical area by applying three increments of resin (Elora, FGM, for Ambar Universal APS Plus and G-ænial A'CHORD, GC, for Solare Bond Universal). Each increment will light cure for 20 s at 900 mW/cm2 (SmartLite Focus, Dentsply). Restorations will be finished immediately with fine and extra fine diamond burs and polished with polishing gums.
48 studies on the registry are indexed under Tooth Erosion; 7 are open to participants now.
This study's enrollment of 35 is close to the median of 34 across 34 interventional studies indexed under Tooth Erosion.
Browse Tooth Erosion studies →Universidad de los Andes, Chile is the lead sponsor of 47 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
35 non-carious cervical lesions (NCCL) will receive composite resin restorations in the selective enamel etch application strategy
Procedure: Enamel Etching time for 5 seconds · Device: Ambar Universal Plus; FGM
35 non-carious cervical lesions (NCCL) will receive composite resin restorations in the selective enamel etch application strategy
Procedure: Enamel Etching time for 5 seconds · Device: Solare Bond Universal; GC
35 non-carious cervical lesions (NCCL) will receive composite resin restorations in the selective enamel etch application strategy
Device: Ambar Universal Plus; FGM · Procedure: Enamel Etching time for 15 seconds
35 non-carious cervical lesions (NCCL) will receive composite resin restorations in the selective enamel etch application strategy
Procedure: Enamel Etching time for 15 seconds · Device: Solare Bond Universal; GC
Composite resin restorations of non-carious cervical lesions will be performed with an adhesive on enamel etched for 5 seconds in the selective enamel etching application strategy.
Composite resin restorations of non-carious cervical lesions will be performed with an universal adhesive (Ambar Universal Plus; FGM).
Composite resin restorations of non-carious cervical lesions will be performed with an adhesive on enamel etched for 15 seconds in the selective enamel etching application strategy.
Composite resin restorations of non-carious cervical lesions will be performed with an universal adhesive (Solare Bond Universal; GC).
Retention of restorations
Retention measured by World Dental Federation (FDI) criteria as following: * VG: Clinically very good - Restoration retained, no fractures / cracks; * G: Clinically good - Small hairline crack; * SS: Clinically sufficient/satisfactory - Two or more or larger hairline cracks and/or chipping (not affecting the marginal integrity); * US: Clinically unsatisfactory - Chipping fractures which damage marginal quality; bulk fractures with or without partial loss (less than half of the restoration); * PO: Clinically poor - (Partial or complete) loss of restoration, (replacement necessary).
Time frame: From date of randomization until twenty four months
Marginal Adaptation of restorations
Marginal Adaptation measured by World Dental Federation (FDI) criteria as following: * VG: Clinically very good - Harmonious outline, no gaps, no discoloration; * G: Clinically good - Small marginal fracture removable by polishing; * SS: Clinically sufficient/satisfactory - Several small enamel or dentin fractures; * US: Clinically unsatisfactory - Notable enamel or dentine wall fracture; * PO: Clinically poor - Filling is loose but in situ.
Time frame: From date of randomization until twenty four months
Marginal Staining of restorations
Marginal Staining measured by World Dental Federation (FDI) criteria as following: * VG: Clinically very good - No marginal staining; * G: Clinically good - Minor marginal staining, easily removable by polishing; * SS: Clinically sufficient/satisfactory - Moderate marginal staining, not esthetically unacceptable; * US: Clinically unsatisfactory - Pronounced marginal staining; major intervention necessary for improvement; * PO: Clinically poor - Deep marginal staining not accessible for intervention
Time frame: From date of randomization until twenty four months
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2026 to primary completion in Sep 2026, 0 months.
Of 21 interventional studies with no phase under Tooth Erosion, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 1 and three quarters within 28. This study's 0 months is below that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad de los Andes, Chile